Filing Details
- Accession Number:
- 0001209191-23-032484
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-05-26 14:53:34
- Reporting Period:
- 2023-05-26
- Accepted Time:
- 2023-05-26 14:53:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1703057 | Abcellera Biologics Inc. | ABCL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1834411 | Andrew Booth | C/O Abcellera Biologics Inc. 2215 Yukon Street Vancouver A1 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Acquisiton | 2023-05-26 | 14,500 | $6.85 | 153,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Shares | 130,959 | Indirect | By spouse |
Billionaire Hedge Funds
